Alpine Immune Sciences to Present at 39th Annual J.P. Morgan Healthcare Conference
Alpine Immune Sciences to Present at 39th Annual J.P. Morgan Healthcare Conference
Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune/inflammatory diseases, today announced the company will present at the 39th Annual J.P. Morgan Healthcare Conference on Thursday, January 14, 2021, at 2:00 p.m. ET/11:00 a.m. PT.
A live webcast of the presentation will be available online in the investor relations section of the companys website at https://ir.alpineimmunesciences.com/events. A replay of the presentation will be available on the company website for 90 days following the webcast.